期刊文献+

尿毒症维持性血液透析患者合并结核分枝杆菌感染调查及其影响因素分析 被引量:3

Investigation of Mycobacterium tuberculosis infection in uremic patients on maintenance hemodialysis and analysis of its influencing factors
原文传递
导出
摘要 目的调查尿毒症维持性血液透析治疗患者合并结核分枝杆菌感染情况并分析其影响因素。方法选择2018年2月—2020年5月在雅安市第二人民医院及成都市公共卫生临床医疗中心接受维持性血液透析治疗的尿毒症患者315例进行研究。收集可能影响尿毒症维持性血液透析治疗患者感染结核分枝杆菌的相关因素,根据结核分枝杆菌感染情况将其分为阴性组与阳性组,采用Logistic回归分析判断各因素的影响。结果315例患者中有60例(19.05%)被确诊为感染结核分枝杆菌。多因素Logistic回归分析显示,女性、有卡介苗接种史、25羟维生素D为尿毒症维持性血液透析治疗患者合并结核分枝杆菌感染的保护性因素(P<0.05);年龄≥60岁、有结核病接触史、有吸烟史、使用抗生素超过2种及使用糖皮质激素和免疫抑制剂为危险因素(P<0.05)。结论尿毒症维持性血液透析治疗患者结核分枝杆菌感染率较高,主要与患者性别、年龄、吸烟史、结核病接触史、卡介苗接种史、25羟维生素D水平及抗生素使用种类、糖皮质激素及免疫抑制剂使用情况有关。 Objective To investigate Mycobacterium tuberculosis infection in uremic patients undergoing maintenance hemodialysis and analyze its influencing factors.Methods A total of 315 uremic patients who received maintenance hemodialysis in Ya’an Second People’s Hospital and Chengdu Public Health Clinical Medical Center from February2018 to May 2020 were selected for the study.The factors associated with M.tuberculosis infection in uremic patients on maintenance hemodialysis were collected.According to the status of M.tuberculosis infection,the patients were divided into negative group and positive group.A logistic regression analysis was performed to determine the influence of each factor.Results A total of 60(19.05%)of the 315 patients were diagnosed with M.tuberculosis infection.The multivariate logistic regression analysis showed that female history of BCG vaccination,and 25-hydroxyvitamin D were the protective factors for M.tuberculosis infection in uremic patients on maintenance hemodialysis(P<0.05).Those age ≥60 years,history of tuberculosis patient contact,smoking history,use of more than two antibiotics,use of glucocorticoid and immunosuppressant were the risk factors(P<0.05).Conclusion The rate of M.tuberculosis infection was higher in uremic patients on maintenance hemodialysis,which was mainly associated with gender,age,smoking history,history of tuberculosis patient contact,history of BCG vaccination,25-hydroxyvitamin D level,and use of antibiotics,glucocorticoid and immunosuppressant.
作者 朱倩莹 程耀 唐建 吴桂辉 ZHU Qian-ying;CHENG Yao;TANG Jian;WU Gui-hui(Department of Nephrology,Second People's Hospital of Ya'an City,Ya'an,Sichuan 625000,China;不详)
出处 《中国国境卫生检疫杂志》 CAS 2021年第2期130-132,共3页 Chinese Journal of Frontier Health and Quarantine
基金 成都市医学科研课题(2019089)。
关键词 尿毒症 血液透析 结核分枝杆菌 Uremia Hemodialysis Mycobacterium tuberculosis
  • 相关文献

参考文献4

二级参考文献23

  • 1刘玉清,屠德华,安燕生,张立兴.大学生结核病控制的研究:(二)结核感染者的预防性治疗[J].中国防痨杂志,2005,27(3):139-142. 被引量:94
  • 2郭彦聪,徐艳春,王小月.维持性血液透析患者并发结核9例回顾性分析[J].中国血液净化,2005,4(9):484-486. 被引量:7
  • 3张贺秋,赵雁林.现代结核病诊断技术.北京:人民卫生出版社,2013:47-103.
  • 4屠德华,万利亚,王黎霞.现代结核病控制理论与实践.2版.北京:军事医学科学出版社,2013:1-8.
  • 5Mack U, Migliori GB, Sester M, et al. LTBh latent tubercu- losis infection or lasting immune response to M. tuberculosis? A TBNET consensus statment. Eur Respir J, 2009,33 (5) : 956-973.
  • 6Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention. Latent tuberculosis infection., a guide for primary health care providers. Atlanta: Centers for Disease Control and Prevention, 2013.
  • 7World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Ge- neva.World Health Organization,2015.
  • 8Dye C, Scheele S, Dolin P, et al. Consensus statement. Glo- bal burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Mo- nitoring Project. JAMA, 1999, 282(7).677-686.
  • 9Gao XF, Wang L, Liu GJ, et al. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a me- ta-analysis. Int J Tubere Lung Dis, 2006, 10(10) : 1080-1090.
  • 10Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med, 2011, 365(23):2155-2166.

共引文献34

同被引文献52

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部